Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/008610
Kind Code:
A1
Abstract:
Provided herein are anti-DLL3 chimeric antigen receptors (CARs), DLL3 binding proteins and uses of such CARs or DLL3 binding proteins in the treatment of DLL3 associated disorders, such as small cell lung cancer.

Inventors:
ZHAO TAO (CN)
PENG YUANYUAN (CN)
TANG AN (CN)
WANG SUJUAN (CN)
YANG SHUAI (CN)
ZHANG WANG (CN)
WU SHU (CN)
HAO RUIDONG (CN)
Application Number:
PCT/CN2020/102717
Publication Date:
January 21, 2021
Filing Date:
July 17, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING LEGEND BIOTECH CO LTD (CN)
International Classes:
C07K19/00; A61P35/00; C07K16/30; C12N15/62
Domestic Patent References:
WO2016138038A12016-09-01
WO2016138038A12016-09-01
WO2019067805A12019-04-04
WO2019067805A12019-04-04
WO2018195348A12018-10-25
WO2018195348A12018-10-25
WO2018044866A12018-03-08
WO2019195408A12019-10-10
WO2019195408A12019-10-10
WO2019200007A12019-10-17
WO2019200007A12019-10-17
WO2018121712A12018-07-05
Foreign References:
CN105153315A2015-12-16
Other References:
OWEN,D.H. ET AL.: "DLL3: an emerging target in small cell lung cancer", JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 12, 18 June 2019 (2019-06-18), XP055693469, DOI: 20200923183843X
OWEN,D.H. ET AL.: "DLL3: an emerging target in small cell lung cancer", JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 12, 18 June 2019 (2019-06-18), XP055693469, DOI: 20200925132149Y
See also references of EP 3999550A4
Attorney, Agent or Firm:
CHENG & PENG INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF: